Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1956 1
1967 1
1972 1
1973 3
1974 3
1975 3
1976 2
1977 4
1978 2
1979 5
1981 5
1982 7
1983 10
1984 5
1985 3
1986 3
1987 3
1988 3
1989 6
1990 8
1991 17
1992 29
1993 14
1994 12
1995 8
1996 10
1997 21
1998 17
1999 19
2000 16
2001 17
2002 14
2003 17
2004 23
2005 21
2006 20
2007 16
2008 12
2009 9
2010 16
2011 12
2012 10
2013 6
2014 8
2015 10
2016 11
2017 10
2018 7
2019 9
2020 8
2021 5
2022 2
2023 4
2024 1
2026 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

477 results

Results by year

Filters applied: . Clear all
Page 1
Galsulfase.
Hopwood JJ, Bate G, Kirkpatrick P. Hopwood JJ, et al. Nat Rev Drug Discov. 2006 Feb;5(2):101-2. doi: 10.1038/nrd1962. Nat Rev Drug Discov. 2006. PMID: 16521329 No abstract available.
Laronidase treatment of mucopolysaccharidosis I.
Wraith EJ, Hopwood JJ, Fuller M, Meikle PJ, Brooks DA. Wraith EJ, et al. Among authors: hopwood jj. BioDrugs. 2005;19(1):1-7. doi: 10.2165/00063030-200519010-00001. BioDrugs. 2005. PMID: 15691212 Review.
Technology for Augmenting Type 1 Diabetes Mellitus Management.
Condren M, Sabet S, Chalmers LJ, Saley T, Hopwood J. Condren M, et al. Among authors: hopwood j. J Pediatr Pharmacol Ther. 2019 Mar-Apr;24(2):99-106. doi: 10.5863/1551-6776-24.2.99. J Pediatr Pharmacol Ther. 2019. PMID: 31019402 Free PMC article. Review.
Implementation of Client Incentives within a Recovery Navigation Program.
Brolin M, Torres M, Hodgkin D, Horgan C, Lee M, Merrick E, Ritter G, Panas L, DeMarco N, Hopwood J, Gewirtz A, Straus J, Harrington J, Lane N. Brolin M, et al. Among authors: hopwood j. J Subst Abuse Treat. 2017 Jan;72:25-31. doi: 10.1016/j.jsat.2016.09.003. Epub 2016 Sep 12. J Subst Abuse Treat. 2017. PMID: 27682892 Review.
Immunochemical analysis of CD107a (LAMP-1).
Parkinson-Lawrence EJ, Dean CJ, Chang M, Hopwood JJ, Meikle PJ, Brooks DA. Parkinson-Lawrence EJ, et al. Among authors: hopwood jj. Cell Immunol. 2005 Jul-Aug;236(1-2):161-6. doi: 10.1016/j.cellimm.2005.08.024. Epub 2005 Sep 15. Cell Immunol. 2005. PMID: 16168398
Common antigenicity for two glycosidases.
Kakavanos R, Lehn P, Callebaut I, Meikle PJ, Parkinson-Lawrence EJ, Hopwood JJ, Brooks DA. Kakavanos R, et al. Among authors: hopwood jj. FEBS Lett. 2006 Jan 9;580(1):87-92. doi: 10.1016/j.febslet.2005.11.053. Epub 2005 Dec 6. FEBS Lett. 2006. PMID: 16359666 Free article.
Epidemiology of lysosomal storage diseases: an overview.
Fuller M, Meikle PJ, Hopwood JJ. Fuller M, et al. Among authors: hopwood jj. In: Mehta A, Beck M, Sunder-Plassmann G, editors. Fabry Disease: Perspectives from 5 Years of FOS. Oxford: Oxford PharmaGenesis; 2006. Chapter 2. In: Mehta A, Beck M, Sunder-Plassmann G, editors. Fabry Disease: Perspectives from 5 Years of FOS. Oxford: Oxford PharmaGenesis; 2006. Chapter 2. PMID: 21290699 Free Books & Documents. Review.
Disease-specific markers for the mucopolysaccharidoses.
Fuller M, Rozaklis T, Ramsay SL, Hopwood JJ, Meikle PJ. Fuller M, et al. Among authors: hopwood jj. Pediatr Res. 2004 Nov;56(5):733-8. doi: 10.1203/01.PDR.0000141987.69757.DD. Epub 2004 Sep 3. Pediatr Res. 2004. PMID: 15347771
477 results